So our findings preliminarily declared that CCDC34 silencing may suppress bladder cancer proliferation and migration through inactivation of RAF-ERK1/2-MAPK, p38/MAPK, JNK/MAPK and PI3K/Akt signaling pathways. Here, RAF1 is linked to urinary bladder cancer.